Detalhe da pesquisa
1.
Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 545-550, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38517658
2.
Effectiveness and safety of granulocyte colony-stimulating factor priming regimen for acute myeloid leukemia: A systematic review and meta-analysis of the Clinical Practice Guideline for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.
Int J Clin Oncol
; 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38755516
3.
Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: a systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan society of clinical oncology.
Int J Clin Oncol
; 29(5): 535-544, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38494578
4.
Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 559-563, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38538963
5.
Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(6): 681-688, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38649648
6.
Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.
Int J Clin Oncol
; 29(6): 700-705, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38696053
7.
Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology.
Int J Clin Oncol
; 29(6): 689-699, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38578596
8.
Primary prophylaxis with G-CSF for patients with non-round cell soft tissue sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology.
Int J Clin Oncol
; 2024 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38865026
9.
Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(4): 355-362, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38353907
10.
Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 551-558, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38526621
11.
[Usefulness of web-based application for health surveys before and after peripheral blood stem cell harvest from healthy donors].
Rinsho Ketsueki
; 65(5): 321-329, 2024.
Artigo
em Japonês
| MEDLINE | ID: mdl-38825508
12.
Exploring the role of insulin-like growth factor binding protein-1 in identifying idiopathic multicentric Castleman's disease types: Implications for the mTOR signaling pathway.
Clin Immunol
; 256: 109798, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37778714
13.
Tandem autologous stem cell transplantation in elderly patients with myeloma: A multicenter retrospective analysis.
Eur J Haematol
; 110(4): 444-454, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36597575
14.
Impact of MRD on clinical outcomes of unrelated hematopoietic stem cell transplantation in patients with Ph+ ALL: A retrospective nationwide study.
Am J Hematol
; 98(10): 1606-1618, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37493218
15.
Clinical significance of late CMV disease in adult patients who underwent allogeneic stem cell transplant.
J Infect Chemother
; 29(12): 1103-1108, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37532223
16.
[Onco-cardiology Guideline-Trends in Japan].
Gan To Kagaku Ryoho
; 50(9): 943-949, 2023 Sep.
Artigo
em Japonês
| MEDLINE | ID: mdl-37800284
17.
The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantation.
Hematol Oncol
; 40(3): 442-456, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35394658
18.
Donor lymphocyte infusion after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia.
Ann Hematol
; 101(3): 643-653, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34988692
19.
Difference of compliance rates for the recommendations in Japanese Guideline on Febrile Neutropenia according to respondents' attributes: the second report on a questionnaire survey among hematology-oncology physicians and surgeons.
Support Care Cancer
; 30(5): 4327-4336, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35094140
20.
The differential effect of disease status at allogeneic hematopoietic cell transplantation on outcomes in acute myeloid and lymphoblastic leukemia.
Ann Hematol
; 100(12): 3017-3027, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34477952